BIO-TECHNE Corp Gross Profit
BIO-TECHNE Corp (TECH) reported Gross Profit of $799.07 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-24.
Financial Statements › Income Statement
us-gaap:GrossProfit · last filed 2026-08-24
- BIO-TECHNE Corp gross profit for the quarter ending 2026-06-30 was $211.39M, a 6.33% increase year-over-year.
- BIO-TECHNE Corp gross profit for the quarter ending 2026-03-31 was $208.29M, a 2.92% decline year-over-year.
- BIO-TECHNE Corp gross profit for the quarter ending 2025-12-31 was $191.28M, a 1.35% decline year-over-year.
- BIO-TECHNE Corp gross profit for the quarter ending 2025-09-30 was $188.11M, a 2.78% increase year-over-year.
- BIO-TECHNE Corp gross profit for fiscal 2026 was $799.07M, a 1.11% increase from fiscal 2025.
- BIO-TECHNE Corp gross profit for fiscal 2025 was $790.27M, a 2.67% increase from fiscal 2024.
- BIO-TECHNE Corp gross profit for fiscal 2024 was $769.73M, a 0.01% decline from fiscal 2023.
- BIO-TECHNE Corp gross profit for fiscal 2023 was $769.82M, a 1.76% increase from fiscal 2022.
| Period end | Gross Profit 3 month | Gross Profit 3 month as first filed | Gross Profit 6 month | Gross Profit 6 month as first filed | Gross Profit 9 month | Gross Profit 9 month as first filed | Gross Profit 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $211.39M derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-24 | $419.68M derived: sum of 2 quarters · filed 2026-08-24 | $610.96M derived: sum of 3 quarters · filed 2026-08-24 | $799.07M 10-K · filed 2026-08-24 | |||
| 2026-03-31 | $208.29M 10-Q · filed 2026-05-06 | $399.56M derived: sum of 2 quarters · filed 2026-05-06 | $587.68M 10-Q · filed 2026-05-06 | $786.49M derived: sum of 4 quarters · filed 2026-08-24 | |||
| 2025-12-31 | $191.28M 10-Q · filed 2026-02-04 | $379.39M 10-Q · filed 2026-02-04 | $578.20M derived: sum of 3 quarters · filed 2026-08-24 | $792.76M derived: sum of 4 quarters · filed 2026-08-24 | |||
| 2025-09-30 | $188.11M 10-Q · filed 2025-11-05 | $386.92M derived: sum of 2 quarters · filed 2026-08-24 | $601.48M derived: sum of 3 quarters · filed 2026-08-24 | $795.37M derived: sum of 4 quarters · filed 2026-08-24 | |||
| 2025-06-30 | $198.81M derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-24 | $413.37M derived: sum of 2 quarters · filed 2026-08-24 | $607.25M derived: sum of 3 quarters · filed 2026-08-24 | $790.27M 10-K · filed 2026-08-24 | |||
| 2025-03-31 | $214.56M 10-Q · filed 2026-05-06 | $408.44M derived: sum of 2 quarters · filed 2026-05-06 | $591.46M 10-Q · filed 2026-05-06 | $794.81M derived: sum of 4 quarters · filed 2026-08-24 | |||
| 2024-12-31 | $193.89M 10-Q · filed 2026-02-04 | $376.90M 10-Q · filed 2026-02-04 | $580.25M derived: sum of 3 quarters · filed 2026-08-24 | $784.85M derived: sum of 4 quarters · filed 2026-08-24 | |||
| 2024-09-30 | $183.02M 10-Q · filed 2025-11-05 | $386.37M derived: sum of 2 quarters · filed 2026-08-24 | $590.96M derived: sum of 3 quarters · filed 2026-08-24 | $767.55M derived: sum of 4 quarters · filed 2026-08-24 | |||
| 2024-06-30 | $203.35M derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-24 | $407.95M derived: sum of 2 quarters · filed 2026-08-24 | $584.53M derived: sum of 3 quarters · filed 2026-08-24 | $769.73M 10-K · filed 2026-08-24 | |||
| 2024-03-31 | $204.60M 10-Q · filed 2025-05-08 | $381.19M derived: sum of 2 quarters · filed 2025-05-08 | $566.38M 10-Q · filed 2025-05-08 | $771.08M derived: sum of 4 quarters · filed 2025-08-22 | |||
| 2023-12-31 | $176.59M 10-Q · filed 2025-02-06 | $361.78M 10-Q · filed 2025-02-06 | $566.48M derived: sum of 3 quarters · filed 2025-08-22 | $768.64M derived: sum of 4 quarters · filed 2025-08-22 | |||
| 2023-09-30 | $185.19M 10-Q · filed 2024-11-05 | $389.89M derived: sum of 2 quarters · filed 2025-08-22 | $592.05M derived: sum of 3 quarters · filed 2025-08-22 | $775.41M derived: sum of 4 quarters · filed 2025-08-22 | |||
| 2023-06-30 | $204.70M derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-22 | $406.86M derived: sum of 2 quarters · filed 2025-08-22 | $590.22M derived: sum of 3 quarters · filed 2025-08-22 | $769.82M 10-K · filed 2025-08-22 | |||
| 2023-03-31 | $202.16M 10-Q · filed 2024-05-06 | $385.52M derived: sum of 2 quarters · filed 2024-05-06 | $565.12M 10-Q · filed 2024-05-06 | $765.47M derived: sum of 4 quarters · filed 2024-08-22 | |||
| 2022-12-31 | $183.36M 10-Q · filed 2024-02-07 | $362.96M 10-Q · filed 2024-02-07 | $563.30M derived: sum of 3 quarters · filed 2024-08-22 | $764.76M derived: sum of 4 quarters · filed 2024-08-22 | |||
| 2022-09-30 | $179.59M 10-Q · filed 2023-11-07 | $379.94M derived: sum of 2 quarters · filed 2024-08-22 | $581.40M derived: sum of 3 quarters · filed 2024-08-22 | $765.09M derived: sum of 4 quarters · filed 2024-08-22 | |||
| 2022-06-30 | $200.35M derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-22 | $401.81M derived: sum of 2 quarters · filed 2024-08-22 | $585.50M derived: sum of 3 quarters · filed 2024-08-22 | $756.50M 10-K · filed 2024-08-22 | |||
| 2022-03-31 | $201.46M 10-Q · filed 2023-05-08 | $385.15M derived: sum of 2 quarters · filed 2023-05-08 | $556.15M 10-Q · filed 2023-05-08 | $732.09M derived: sum of 4 quarters · filed 2023-08-23 | |||
| 2021-12-31 | $183.69M 10-Q · filed 2023-02-07 | $354.69M 10-Q · filed 2023-02-07 | $530.63M derived: sum of 3 quarters · filed 2023-08-23 | $698.91M derived: sum of 4 quarters · filed 2023-08-23 | |||
| 2021-09-30 | $171.00M 10-Q · filed 2022-11-07 | $346.94M derived: sum of 2 quarters · filed 2023-08-23 | $515.22M derived: sum of 3 quarters · filed 2023-08-23 | $666.12M derived: sum of 4 quarters · filed 2023-08-23 | |||
| 2021-06-30 | $175.94M derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-23 | $344.22M derived: sum of 2 quarters · filed 2023-08-23 | $495.12M derived: sum of 3 quarters · filed 2023-08-23 | $632.85M 10-K · filed 2023-08-23 | |||
| 2021-03-31 | $168.27M 10-Q · filed 2022-05-09 | $319.17M derived: sum of 2 quarters · filed 2022-05-09 | $456.91M 10-Q · filed 2022-05-09 | $570.22M derived: sum of 4 quarters · filed 2022-08-24 | |||
| 2020-12-31 | $150.90M 10-Q · filed 2022-02-07 | $288.63M 10-Q · filed 2022-02-07 | $401.94M derived: sum of 3 quarters · filed 2022-08-24 | $532.01M derived: sum of 4 quarters · filed 2022-08-24 | |||
| 2020-09-30 | $137.73M 10-Q · filed 2021-11-08 | $251.04M derived: sum of 2 quarters · filed 2022-08-24 | $381.11M derived: sum of 3 quarters · filed 2022-08-24 | $502.51M derived: sum of 4 quarters · filed 2022-08-24 | |||
| 2020-06-30 | $113.31M derived: 10-K 12 month − 10-Q 9 month · filed 2022-08-24 | $243.38M derived: sum of 2 quarters · filed 2022-08-24 | $364.78M derived: sum of 3 quarters · filed 2022-08-24 | $483.19M 10-K · filed 2022-08-24 | |||
| 2020-03-31 | $130.06M 10-Q · filed 2021-05-07 | $251.47M derived: sum of 2 quarters · filed 2021-05-07 | $369.88M 10-Q · filed 2021-05-07 | $498.14M derived: sum of 4 quarters · filed 2021-08-25 | |||
| 2019-12-31 | $121.40M 10-Q · filed 2021-02-08 | $239.82M 10-Q · filed 2021-02-08 | $368.08M derived: sum of 3 quarters · filed 2021-08-25 | $492.69M derived: sum of 4 quarters · filed 2021-08-25 | |||
| 2019-09-30 | $118.41M 10-Q · filed 2020-11-09 | $246.67M derived: sum of 2 quarters · filed 2021-08-25 | $371.28M derived: sum of 3 quarters · filed 2021-08-25 | $484.30M derived: sum of 4 quarters · filed 2021-08-25 | |||
| 2019-06-30 | $128.26M derived: 10-K 12 month − 10-Q 9 month · filed 2021-08-25 | $252.87M derived: sum of 2 quarters · filed 2021-08-25 | $365.89M derived: sum of 3 quarters · filed 2021-08-25 | $473.49M 10-K · filed 2021-08-25 | |||
| 2019-03-31 | $124.61M 10-Q · filed 2020-05-11 | $237.63M derived: sum of 2 quarters · filed 2020-05-11 | $345.23M 10-Q · filed 2020-05-11 | $467.41M derived: sum of 4 quarters · filed 2020-08-26 | |||
| 2018-12-31 | $113.02M 10-Q · filed 2020-02-06 | $220.62M 10-Q · filed 2020-02-06 | $342.80M derived: sum of 3 quarters · filed 2020-08-26 | $453.06M derived: sum of 4 quarters · filed 2020-08-26 | |||
| 2018-09-30 | $107.60M 10-Q · filed 2019-11-06 | $229.78M derived: sum of 2 quarters · filed 2020-08-26 | $340.05M derived: sum of 3 quarters · filed 2020-08-26 | $441.88M derived: sum of 4 quarters · filed 2020-08-26 | |||
| 2018-06-30 | $122.18M derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-26 | $232.44M derived: sum of 2 quarters · filed 2020-08-26 | $334.28M derived: sum of 3 quarters · filed 2020-08-26 | $432.14M 10-K · filed 2020-08-26 | |||
| 2018-03-31 | $110.26M 10-Q · filed 2019-05-07 | $212.09M derived: sum of 2 quarters · filed 2019-05-07 | $309.96M 10-Q · filed 2019-05-07 | $412.33M derived: sum of 4 quarters · filed 2019-11-06 | |||
| 2017-12-31 | $101.83M 10-Q · filed 2019-02-07 | $199.70M 10-Q · filed 2019-02-07 | $302.07M derived: sum of 3 quarters · filed 2019-11-06 | $398.76M derived: sum of 4 quarters · filed 2019-11-06 | |||
| 2017-09-30 | $97.87M 10-Q · filed 2018-11-07 | $200.24M derived: sum of 2 quarters · filed 2019-11-06 | $296.92M derived: sum of 3 quarters · filed 2019-11-06 | $385.06M derived: sum of 4 quarters · filed 2019-11-06 | |||
| 2017-06-30 | $102.37M derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-11-06 | $199.05M derived: sum of 2 quarters · filed 2019-11-06 | $287.20M derived: sum of 3 quarters · filed 2019-11-06 | $374.54M 10-K/A · filed 2019-11-06 | |||
| 2017-03-31 | $96.68M 10-Q · filed 2018-05-09 | $94.18M 10-Q · filed 2017-05-10 | $184.82M derived: sum of 2 quarters · filed 2018-05-09 | $272.17M 10-Q · filed 2018-05-09 | $263.73M 10-Q · filed 2017-05-10 | $361.86M derived: sum of 4 quarters · filed 2018-08-27 | |
| 2016-12-31 | $88.14M 10-Q · filed 2018-02-08 | $85.08M 10-Q · filed 2017-02-09 | $175.49M 10-Q · filed 2018-02-08 | $169.55M 10-Q · filed 2017-02-09 | $265.18M derived: sum of 3 quarters · filed 2018-08-27 | $355.17M derived: sum of 4 quarters · filed 2018-08-27 | |
| 2016-09-30 | $87.34M 10-Q · filed 2017-11-09 | $84.47M 10-Q · filed 2016-11-09 | $177.04M derived: sum of 2 quarters · filed 2018-08-27 | $267.03M derived: sum of 3 quarters · filed 2018-08-27 | $348.61M derived: sum of 4 quarters · filed 2018-08-27 | ||
| 2016-06-30 | $89.69M derived: 10-K 12 month − 10-Q 9 month · filed 2018-08-27 | $179.68M derived: sum of 2 quarters · filed 2018-08-27 | $261.27M derived: sum of 3 quarters · filed 2018-08-27 | $336.66M 10-K · filed 2018-08-27 | |||
| 2016-03-31 | $89.99M 10-Q · filed 2017-05-10 | $171.58M derived: sum of 2 quarters · filed 2017-05-10 | $246.97M 10-Q · filed 2017-05-10 | $326.06M derived: sum of 4 quarters · filed 2017-09-07 | |||
| 2015-12-31 | $81.59M 10-Q · filed 2017-02-09 | $156.98M 10-Q · filed 2017-02-09 | $236.07M derived: sum of 3 quarters · filed 2017-09-07 | $315.45M derived: sum of 4 quarters · filed 2017-09-07 | |||
| 2015-09-30 | $75.39M 10-Q · filed 2016-11-09 | $154.48M derived: sum of 2 quarters · filed 2017-09-07 | $233.86M derived: sum of 3 quarters · filed 2017-09-07 | $309.60M derived: sum of 4 quarters · filed 2017-09-07 | |||
| 2015-06-30 | $79.09M derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-07 | $158.47M derived: sum of 2 quarters · filed 2017-09-07 | $234.21M derived: sum of 3 quarters · filed 2017-09-07 | $307.28M 10-K · filed 2017-09-07 | |||
| 2015-03-31 | $79.38M 10-Q · filed 2016-05-10 | $155.12M derived: sum of 2 quarters · filed 2016-05-10 | $228.19M 10-Q · filed 2016-05-10 | $291.78M derived: sum of 4 quarters · filed 2016-08-29 | |||
| 2014-12-31 | $75.74M 10-Q · filed 2016-02-09 | $148.81M 10-Q · filed 2016-02-09 | $212.40M derived: sum of 3 quarters · filed 2016-08-29 | $280.51M derived: sum of 4 quarters · filed 2016-08-29 | |||
| 2014-09-30 | $73.07M 10-Q · filed 2015-11-09 | $136.66M derived: sum of 2 quarters · filed 2016-08-29 | $204.77M derived: sum of 3 quarters · filed 2016-08-29 | $263.36M derived: sum of 4 quarters · filed 2016-08-29 | |||
| 2014-06-30 | $63.59M derived: 10-K 12 month − 10-Q 9 month · filed 2016-08-29 | $131.70M derived: sum of 2 quarters · filed 2016-08-29 | $190.30M derived: sum of 3 quarters · filed 2016-08-29 | $251.41M 10-K · filed 2016-08-29 | |||
| 2014-03-31 | $68.11M 10-Q · filed 2015-05-11 | $126.70M derived: sum of 2 quarters · filed 2015-05-11 | $187.82M 10-Q · filed 2015-05-11 | $246.94M derived: sum of 4 quarters · filed 2015-08-31 | |||
| 2013-12-31 | $58.59M 10-Q · filed 2015-02-09 | $119.71M 10-Q · filed 2015-02-09 | $178.82M derived: sum of 3 quarters · filed 2015-08-31 | $239.97M derived: sum of 4 quarters · filed 2015-08-31 | |||
| 2013-09-30 | $61.11M 10-Q · filed 2014-11-10 | $120.23M derived: sum of 2 quarters · filed 2015-08-31 | $181.38M derived: sum of 3 quarters · filed 2015-08-31 | $236.64M derived: sum of 4 quarters · filed 2015-08-31 | |||
| 2013-06-30 | $59.12M derived: 10-K 12 month − 10-Q 9 month · filed 2015-08-31 | $120.26M derived: sum of 2 quarters · filed 2015-08-31 | $175.53M derived: sum of 3 quarters · filed 2015-08-31 | $231.11M 10-K · filed 2015-08-31 | |||
| 2013-03-31 | $61.15M 10-Q · filed 2014-05-12 | $116.41M derived: sum of 2 quarters · filed 2014-05-12 | $171.99M 10-Q · filed 2014-05-12 | $230.86M derived: sum of 4 quarters · filed 2014-08-29 | |||
| 2012-12-31 | $55.26M 10-Q · filed 2014-02-04 | $110.85M 10-Q · filed 2014-02-04 | $169.71M derived: sum of 3 quarters · filed 2014-08-29 | $233.09M derived: sum of 4 quarters · filed 2014-08-29 | |||
| 2012-09-30 | $55.58M 10-Q · filed 2013-11-12 | $114.45M derived: sum of 2 quarters · filed 2014-08-29 | $177.83M derived: sum of 3 quarters · filed 2014-08-29 | $233.00M derived: sum of 4 quarters · filed 2014-08-29 | |||
| 2012-06-30 | $58.86M derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-29 | $122.25M derived: sum of 2 quarters · filed 2014-08-29 | $177.42M derived: sum of 3 quarters · filed 2014-08-29 | $235.80M 10-K · filed 2014-08-29 | |||
| 2012-03-31 | $63.38M 10-Q · filed 2013-05-10 | $118.55M derived: sum of 2 quarters · filed 2013-05-10 | $176.94M 10-Q · filed 2013-05-10 | $236.57M derived: sum of 4 quarters · filed 2013-08-29 | |||
| 2011-12-31 | $55.17M 10-Q · filed 2013-02-11 | $113.56M 10-Q · filed 2013-02-11 | $173.19M derived: sum of 3 quarters · filed 2013-08-29 | $233.52M derived: sum of 4 quarters · filed 2013-08-29 | |||
| 2011-09-30 | $58.39M 10-Q · filed 2012-11-09 | $118.02M derived: sum of 2 quarters · filed 2013-08-29 | $178.35M derived: sum of 3 quarters · filed 2013-08-29 | $230.73M derived: sum of 4 quarters · filed 2013-08-29 | |||
| 2011-06-30 | $59.63M derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-29 | $119.96M derived: sum of 2 quarters · filed 2013-08-29 | $172.34M derived: sum of 3 quarters · filed 2013-08-29 | $224.94M 10-K · filed 2013-08-29 | |||
| 2011-03-31 | $60.33M 10-Q · filed 2012-05-10 | $60.44M 10-Q · filed 2011-05-10 | $112.71M derived: sum of 2 quarters · filed 2012-05-10 | $165.31M 10-Q · filed 2012-05-10 | $165.63M 10-Q · filed 2011-05-10 | $217.75M derived: sum of 4 quarters · filed 2012-08-29 | |
| 2010-12-31 | $52.38M 10-Q · filed 2012-02-07 | $52.49M 10-Q · filed 2011-02-09 | $104.98M 10-Q · filed 2012-02-07 | $105.19M 10-Q · filed 2011-02-09 | $157.42M derived: sum of 3 quarters · filed 2012-08-29 | $213.30M derived: sum of 4 quarters · filed 2012-08-29 | |
| 2010-09-30 | $52.59M 10-Q · filed 2011-11-09 | $52.70M 10-Q · filed 2010-11-09 | $105.04M derived: sum of 2 quarters · filed 2012-08-29 | $160.92M derived: sum of 3 quarters · filed 2012-08-29 | $213.11M derived: sum of 4 quarters · filed 2012-08-29 | ||
| 2010-06-30 | $52.45M derived: 10-K 12 month − 10-Q 9 month · filed 2012-08-29 | $108.32M derived: sum of 2 quarters · filed 2012-08-29 | $160.52M derived: sum of 3 quarters · filed 2012-08-29 | $214.15M 10-K · filed 2012-08-29 | |||
| 2010-03-31 | $55.88M 10-Q · filed 2011-05-10 | $108.07M derived: sum of 2 quarters · filed 2011-05-10 | $161.70M 10-Q · filed 2011-05-10 | ||||
| 2009-12-31 | $52.19M 10-Q · filed 2011-02-09 | $105.83M 10-Q · filed 2011-02-09 | |||||
| 2009-09-30 | $53.63M 10-Q · filed 2010-11-09 | ||||||
| 2009-06-30 | $208.03M 10-K · filed 2011-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |